Induction of apoptosis of activated murine splenic T cells by cycloprodigiosin hydrochloride, a novel immunosuppressant

被引:36
作者
Azuma, T
Watanabe, N
Yagisawa, H
Hirata, K
Iwamura, M
Kobayashi, Y
机构
[1] Toho Univ, Fac Sci, Dept Biomol Sci, Chiba 2748510, Japan
[2] Himeji Inst Technol, Fac Sci, Dept Life Sci, Kamigori, Hyogo 67812, Japan
来源
IMMUNOPHARMACOLOGY | 2000年 / 46卷 / 01期
关键词
immunosuppressant; cycloprodigiosin; apoptosis; cell-type specificity;
D O I
10.1016/S0162-3109(99)00153-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Two types of immunosuppressants, cycloprodigiosin hydrochloride (cPrG) and L-leucyl-L-leucine methyl ester (LeuLeuOMe), both have the ability to selectively inhibit the lysosomal function, and a related compound to cPrG, prodigiosin 25-C, and LeuLeuOMe have been reported to selectively inhibit the T cell function in vitro. We therefore examined the cell-type specificity of cPrG and LeuLeuOMe using murine splenocytes. Concanavalin A (Con A)- and lentil lectin-induced proliferation was suppressed by cPrG more profoundly than lipopolysaccharide-induced proliferation. At the optimal concentration, Con A induced the proliferation of both CD4+ and CD8+ cells, whereas at a supra-optimal concentration Con A induced rather selective proliferation of CD8+ cells. Irrespective of the dose of Con A, CD4+ and CD8+ cells were equally affected by cPrG. In contrast, LeuLeuOMe induced the selective loss of CD8+ cells. cPrG enhanced the apoptosis of murine splenocytes and nylon fiber column-purified T cells cultured in the presence of Con A, as shown by the decrease in cell size and/or DNA fragmentation. Overall, this study revealed that the cell-type specificity of cPrG is different from that of LeuLeuOMe, and that the immunosuppression by cPrG is associated with apoptosis. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:29 / 37
页数:9
相关论文
共 19 条
  • [1] Induction of selective cell death targeting on mature T-lymphocytes in rats by a novel immunosuppressant, FTY720
    Enosawa, S
    Suzuki, S
    Kakefuda, T
    Li, XK
    Amemiya, H
    [J]. IMMUNOPHARMACOLOGY, 1996, 34 (2-3): : 171 - 179
  • [2] RAPID METHOD FOR ISOLATION OF FUNCTIONAL THYMUS-DERIVED MURINE LYMPHOCYTES
    JULIUS, MH
    SIMPSON, E
    HERZENBERG, LA
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1973, 3 (10) : 645 - 649
  • [3] PRODIGIOSIN 25-C UNCOUPLES VACUOLAR-TYPE H+-ATPASE, INHIBITS VACUOLAR ACIDIFICATION AND AFFECTS GLYCOPROTEIN PROCESSING
    KATAOKA, T
    MUROI, M
    OHKUMA, S
    WARITANI, T
    MAGAE, J
    TAKATSUKI, A
    KONDO, S
    YAMASAKI, M
    NAGAI, K
    [J]. FEBS LETTERS, 1995, 359 (01): : 53 - 59
  • [4] ENHANCEMENT BY CONCANAVALIN-A OF THE SUPPRESSIVE EFFECT OF PRODIGIOSIN 25-C ON PROLIFERATION OF MURINE SPLENOCYTES
    KATAOKA, T
    MAGAE, J
    NARIUCHI, H
    YAMASAKI, M
    NAGAI, K
    [J]. JOURNAL OF ANTIBIOTICS, 1992, 45 (08) : 1303 - 1312
  • [5] A possible immunosuppressant, cycloprodigiosin hydrochloride, obtained from Pseudoalteromonas denitrificans
    Kawauchi, K
    Shibutani, K
    Yagisawa, H
    Kamata, H
    Nakatsuji, S
    Anzai, H
    Yokoyama, Y
    Ikegami, Y
    Moriyama, Y
    Hirata, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 237 (03) : 543 - 547
  • [6] FK506 AND CYCLOSPORINE, MOLECULAR PROBES FOR STUDYING INTRACELLULAR SIGNAL-TRANSDUCTION (REPRINTED FROM TRENDS IN PHARMACOLOGICAL SCIENCES, VOL 14, PG 182-189, 1993)
    LIU, J
    [J]. IMMUNOLOGY TODAY, 1993, 14 (06): : 290 - 295
  • [7] FK506 AUGMENTS ACTIVATION-INDUCED PROGRAMMED CELL-DEATH OF T-LYMPHOCYTES IN-VIVO
    MIGITA, K
    EGUCHI, K
    KAWABE, Y
    TSUKADA, T
    MIZOKAMI, A
    NAGATAKI, S
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) : 727 - 732
  • [8] SUPPRESSION OF CYTO-TOXIC T-CELL INDUCTION INVIVO BY PRODIGIOSIN 25-C
    NAKAMURA, A
    MAGAE, J
    TSUJI, RF
    YAMASAKI, M
    NAGAI, K
    [J]. TRANSPLANTATION, 1989, 47 (06) : 1013 - 1016
  • [9] NAKANO T, 1980, J IMMUNOL, V125, P1928
  • [10] Cross-linking the TCR complex induces apoptosis in CD4(+)8(+) thymocytes in the presence of cyclosporin A
    Poetschke, HL
    Klug, DB
    Walker, D
    Richie, ER
    [J]. DEVELOPMENTAL IMMUNOLOGY, 1996, 5 (01): : 1 - 15